Koyfin Home > Directory > Health Care > Arena Pharmaceuticals > Price / Book

Arena Pharmaceuticals Price / Book Chart (ARNA)

Arena Pharmaceuticals annual/quarterly Price / Book from 2000 to 2018. Price-to-book value (P/B) is the ratio of market value of a company's shares (share price) over its book value of equity. The book value of equity, in turn, is the value of a company's assets expressed on the balance sheet.
  • Arena Pharmaceuticals Price / Book for the quarter ending March 03, 2018 was 7.49 a -168.68% decrease of -12.63 year over year
  • Arena Pharmaceuticals Annual Price / Book for 2017 was 6.10 a -1,602.08% decrease of -97.72 from 2016
  • Arena Pharmaceuticals Annual Price / Book for 2016 was 103.82 a 94.60% increase of 98.21 from 2015
  • Arena Pharmaceuticals Annual Price / Book for 2015 was 5.61 a -78.59% decrease of -4.41 from 2014
Other Valuation Metrics:
  • Arena Pharmaceuticals Market Cap for the quarter ending March 03, 2018 was $1,938m a 72.36% increase of 1,402m year over year
  • Arena Pharmaceuticals Enterprise Value for the quarter ending March 03, 2018 was $1,752m a 70.30% increase of 1,232m year over year
View Chart On Koyfin

Quarterly ARNA Price / Book Data

03/20187.49
12/20176.10
09/201712.08
06/201720.13
03/20178.91
12/2016103.82
09/201631.40
06/201611.07
03/20168.94
12/20155.61

Annual ARNA Price / Book Data

20176.10
2016103.82
20155.61
201410.01
201311.41
201216.71
20117.77
20101.98
20093.21
20081.75